Transgenomic (TBIO) Misses Q3 EPS by 7c
Tweet
Share
E-mail
Get Alerts TBIO Hot Sheet
Price: $3.23 --0%
Financial Fact:
LOSS FROM OPERATIONS: -1.62M
Today's EPS Names:
TWIN, FLO, ATHM, More
Financial Fact:
LOSS FROM OPERATIONS: -1.62M
Today's EPS Names:
TWIN, FLO, ATHM, More
Join SI Premium – FREE
Transgenomic (NASDAQ: TBIO) reported Q3 EPS of ($0.37), $0.07 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $7.4 million.
For earnings history and earnings-related data on Transgenomic (TBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Coty (COTY) Misses Q4 EPS by 1c, offers outlook
- Exyn Technologies, Inc. (EXYN) Reports Q2 Loss of $1.55
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
